1. Therapeutic challenges in a patient with the simple virilizing (SV) form of congenital adrenal hyperplasia (CAH) due to the P30L/I172N genotype
- Author
-
Maja Tankoska, Michel K. Naydenov, Violeta Anastasovska, Marina Krstevska-Konstantinova, and Mirjana Kocova
- Subjects
0301 basic medicine ,business.industry ,medicine.drug_class ,Endocrinology, Diabetes and Metabolism ,Virilization ,Physiology ,030209 endocrinology & metabolism ,Bone age ,Androgen ,medicine.disease ,Pubarche ,Pubic hair ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Endocrinology ,medicine.anatomical_structure ,Pediatrics, Perinatology and Child Health ,Genotype ,medicine ,Congenital adrenal hyperplasia ,medicine.symptom ,business ,Hydrocortisone ,medicine.drug - Abstract
Background Steroid 21-hydroxylase deficiency is an autosomal recessive disorder, present in 90–95% of all cases with congenital adrenal hyperplasia (CAH). The classical simple virilizing (SV) form of the disease causes virilization of the external genitalia in newborn females and pseudo-precocious puberty in both sexes, due to reactive androgen overproduction. Case presentation We describe a 3.5-year-old girl presenting with pubarche, P2 according to Tanner, advanced bone age of 6 years and 10 months, and high serum levels of 17-hydroxyprogesterone (17-OHP). Molecular analysis of the nine most common pseudogene-derived CYP21A2 point mutations was performed in the patient and her family members using the polymerase chain reaction/amplification-created restriction site (PCR/ACRS) method. We detected the P30L/I172N genotype in the patient. She had inherited a mild P30L mutation from her mother and a severe I172N mutation from her father. Conclusions Although the CAH phenotype is determined by the allele that produces most of the enzyme activity and the mild non-classical (NC) phenotype should be expected, the mild P30L known to be more virilizing probably induced the classical SV phenotype in our patient. A continuous regimen of hydrocortisone at a recommended dose failed to decrease the 17-OHP sufficiently. Careful tapering of the dose did not help, and her pubic hair advanced to P3 according to Tanner. Individually tailored treatment is warranted in this patient.
- Published
- 2019
- Full Text
- View/download PDF